DOCSLIB.ORG

Exploring the Lewis Acid Assisted 19F/18F-Isotopic Exchange Radiochemistry of BODIPY Dyes, and Dipods: Development of A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Expanding the Toolbox: Exploring the Lewis Acid Assisted 19F/18F-Isotopic Exchange Radiochemistry of BODIPY Dyes, and DiPODS: Development of a Novel Bioconjugation Reagent. A Thesis Submitted to the College of Graduate & Postdoctoral Studies In Partial Fulfillment of the Requirements For the Degree of Master of Science In the Department of Chemistry University of Saskatchewan Saskatoon By Whitney Shannon © Copyright Whitney Shannon, March 1st, 2021. All rights reserved. Unless otherwise noted, copyright of the material in this thesis belongs to the author. Permission to Use In presenting this thesis in partial fulfillment of the requirements for a graduate degree from the University of Saskatchewan, I agree that the Libraries of this University may make it freely available for inspection. I further agree that permission for copying of this thesis in any manner, in whole or in part, for scholarly purposes may be granted by the professors who supervised this thesis work or, in their absences, by the Head of the Department or the Dean of the College in which my thesis work was done. It is understood that any copying or publication or use of this thesis or parts thereof for financial gain shall not be allowed without my written permission. It is also understood that due recognition shall be given to me and to the University of Saskatchewan in any scholarly use which may be made of any material in my thesis. Requests for permission to copy or to make other use of material in this thesis in whole or in part should be addressed to: Head of the Department of Chemistry Dean of College of Graduate & Postdoctoral Studies 170 Thorvaldson Building, 110 Science Place 116 Thorvaldson Building, 110 Science Place University of Saskatchewan University of Saskatchewan Saskatoon, Saskatchewan S7N 5C9 Saskatoon, Saskatchewan S7N 5C9 Canada Canada i Abstract Radiochemical diagnostics and therapeutics benefit from pairing with a compliment second imaging modality. However, methods to radiolabel and link these molecules to targeting vectors are problematic. In this dissertation, I explored new radiosynthetic strategies for producing fluorophore-based bimodal agents and new bioconjugation reagents for antibody drug conjugation with improved in vivo stability. 18F-radiolabeled 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) fluorophores are hypothetically ideal bimodal imaging candidates. Preliminary experiments focused on facilitating 19F/18F-transfluorination of Pseudomonas aeruginosa-selective BODIPY dye, CDy11, using Lewis acidic [18F]F-BODIPY labeling strategies described in literature. However, the conventionally applied tin(IV)-chloride (SnCl4) Lewis acid’s instability affords reaction yield variability, and further promoted degradation of the CDy11. Thus, research transitioned towards investigating an alternative Lewis acid. To our knowledge, we are the first to use hydrated 18 magnesium nitrate [Mg(NO3)2] as an air-stable substitute for promoting F-fluorination of commercially-available BODIPY dyes. Order of reagent addition significantly affected the 19F/18F-isotopic exchange reaction; with addition of azeotropically dried [18F]F-TBAF to a mixture of the commercial dye and Lewis acidic agent proving most effective. 19F/18F-transfluorination was achieved using both SnCl4 and Mg(NO3)2 to varying degrees. Increasing the equivalences of applied Mg(NO3)2 salt generally improved radiochemical yields. Bioconjugation chemistry enables the covalent attachment of molecules of interest to larger proteins such as antibodies. While conjugation with thiol groups (cysteine) in antibodies is common, conventional maleimide-based coupling agents are prone to in vivo hydrolysis. Price lab research efforts sought to develop radioimmunoconjugates that operate through two phenyloxadiazolyl methyl sulfone (DiPODS) functionality to form irreversible bonds with antibody cysteine pairs. My contribution was to assist in synthesizing several of the multistep synthesis products and apply spectroscopic methods towards analysis of the initial step’s product mixture, which was hypothesized to exist as a rotameric mixture. Several intermediate agents were ii successfully synthesized to produce the desired DIPODS end product. The three components of the 5-[[(1,1-dimethylethoxy)carbonyl]amino]-1,3-dimethyl ester (compound 1)product mixture were attributed to an inseparable mixture of rotamers, doubly-di-tert-butyl decarbonate (Boc)- protected derivative of the compound, and imidic acid tautomers using spectroscopic methods including variable temperature 1H NMR. Lastly, an additional chemical species was observed via 1H NMR as temperature was increased to 75 °C and attributed to a second set of product rotamers. Ultimately, this thesis served to improve future radiotherapeutic agents and radio-diagnostics through the investigation of alternative and reproducible [18F]F-BODIPY labeling strategies and radioimmunoconjugates of improved stability. iii Acknowledgements In an attempt to thank all those who have made this body of work possible, foremost gratitude must be given to my co-supervisors, Dr. Eric Price and Dr. Steven Siciliano. Thank you both for your guidance, support, patience, and for the privilege to learn from both of your expertise. Sincerest thanks to my laboratory colleagues for many laughs and lessons. Special thanks must be given to the staff of the Sylvia Fedoruk Canadian Centre for Nuclear Innovation for providing a safe and enthusiastic work environment, Kelly Christopher for bringing so much life and enthusiasm into any and all research spaces and to Dr. Elaheh Khozeimeh Sarbisheh for being both a role model and mentor. Thank you for believing in me and pushing me to strive for excellence. I would like to thank the Department of Chemistry, the College of Arts and Science, and the College of Graduate and Postdoctoral Studies at the University of Saskatchewan, my committee members as well as the funding agencies whom have contributed to the work performed during the course of my graduate studies; namely the NSERC CREATE SAFER program. Lastly, to my family, whom has always been my greatest source of love and inspiration, none of this would have been possible without you. Thank you for exemplifying what it means to be both hard working and caring. To my parents especially, the person I am today is credited to you and being your daughter is my greatest source of pride. Thanks Everyone, Whitney Shannon iv Table of Contents Permission to Use ........................................................................................................................... i Abstract .......................................................................................................................................... ii Acknowledgements ...................................................................................................................... iv Table of Contents .......................................................................................................................... v List of Tables ................................................................................................................................ xi List of Figures ............................................................................................................................. xiii List of Schemes ....................................................................................................................... xxxiii Glossary of Abbreviations and Symbols .............................................................................. xxxvi General Introduction .................................................................................................................... 1 Radiochemistry ....................................................................................................................... 1 1.1. Fluorine-18 ([18F]F-). ....................................................................................................... 3 1.1.1. Fluorine in Medicine. ................................................................................................ 3 1.1.2. Fluorine-18 Radioisotope.......................................................................................... 3 1.2. ( 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) BODIPY Dyes. ....................................... 6 1.2.1. Optical Imaging. ....................................................................................................... 7 1.2.2. Positron Emission Tomography (PET). .................................................................... 7 1.2.3. Optical/PET Dual-Modality. ..................................................................................... 9 1.3. [18F]-Labeling Strategies for BODIPY Dyes. .................................................................. 9 v 1.3.1. Brønsted-Lowry Acid/Base Theory .......................................................................... 9 1.3.2. Brønsted-Lowry Acid-Assisted 19F/18F-Isotopic Exchange.................................... 10 1.3.3. Lewis Acids/Base Theory. ...................................................................................... 11 1.3.4. Hard Soft Lewis Acid Base (HSAB) Theory & Lewis Acid Selection. ................. 12 1.3.5. Lewis Acid-Assisted 19F/18F-Isotopic Exchange. ................................................... 13 1.4. Antibody Drug Conjugates. ........................................................................................... 14 1.4.1. Cleavable and Non-Cleavable
Recommended publications
  • Fluorophosphonium Chemistry: Applying Strategies Learned from Boron to Phosphorus

    Fluorophosphonium Chemistry: Applying Strategies Learned from Boron to Phosphorus

    Fluorophosphonium Chemistry: Applying Strategies Learned from Boron to Phosphorus by Shawn William Postle A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Chemistry University of Toronto Fluorophosphonium Chemistry: Applying Strategies Learned from Boron to Phosphorus Shawn William Postle Doctor of Philosophy Department of Chemistry University of Toronto Abstract Since the inception of frustrated Lewis pair chemistry, interest in main group catalysts has undergone a resurgence. Central to the success of many main group systems is the pentafluorophenyl substituent, which provides both chemical stability and electrophilicity to the catalyst. Pentafluorophenyl substituents have been used with boranes, alanes, and recently in fluorophosphonium cations. This thesis investigates a range of related aryl substituents applied to fluorophosphonium chemistry to elicit new catalyst properties. Nitrene insertion into the bonds of borane substituents, including perfluorophenyl groups, was used to tune the electrophilicity of main group systems. Sterically demanding pentachlorophenyl substituents were used to add protection to sensitive fluorophosphonium catalysts. Perfluorobiphenyl groups were used to generate more electrophilic fluorophosphonium catalysts. Binaphthyl substituents were employed to create chiral fluorophosphonium cations. ii This work is dedicated in memory of my grandpa, William Kerr, for instilling in me a genuine curiosity of the world. iii Acknowledgements First and foremost, I would like to thank Prof. Doug Stephan for providing me with this experience. By providing me with the freedom to pursue my own interests and offering insightful guidance whenever it was sought, you have helped me become a better chemist. I would like to thank my committee members, Prof. Bob Morris and Prof.
  • (12) United States Patent (10) Patent No.: US 9.447,114 B2 Chenard Et Al

    (12) United States Patent (10) Patent No.: US 9.447,114 B2 Chenard Et Al

    USOO94471.14B2 (12) United States Patent (10) Patent No.: US 9.447,114 B2 Chenard et al. (45) Date of Patent: Sep. 20, 2016 (54) THIENO- AND 2015,0111038 A1* 4, 2015 Kadam ................ CO7D 495/04 FURO2,3-DIPYRIMIDINE-2,41H,3H-DIONE 2015,0190366 A1* 7, 2015 Hous Agik ; : DERVATIVES OuSley ............... 5.14?6.5 2016/0046624 A1 2/2016 Chenard .............. CO7D 471/04 (71) Applicant: Hydra Biosciences, Inc., Cambridge, 514,264.1 MA (US) FOREIGN PATENT DOCUMENTS (72) Inventors: Bertrand L. Chenard, Waterford, CT (US); Randall J. Gallaschun, Lebanon, JP EP 0640606 A1 * 3, 1995 ........... A61K 31.505 WO WO O2O64572 A1 * 8, 2002 ... A64K 31,517 CT (US) WO WO-2004O28634 A1 4/2004 WO WO-2008070529 A2 6, 2008 (73) Assignee: Hydra Biosciences, Inc., Cambridge, WO WO-2010017368 A2 2, 2010 MA (US) OTHER PUBLICATIONS (*) Notice: Subject to any disclaimer, the term of this CAS Registry No. 606122-61-6 (Entered STN: Oct. 17, 2003).* patent is extended or adjusted under 35 CAS Registry No. 1497903-60-2 (Entered STN: Dec. 18, 2013).* U.S.C. 154(b) by 0 days. CAS Registry Nos. (Indexed 2012).* CAS Registry Nos. (Indexed 2006).* (21) Appl. No.: 14/822,018 C. Hong et al., 138 Brain, 3030-3047 (2015).* K.D. Phelan et al., 83 Molecular Pharmacology, 429–438 (2013).* (22) Filed: Aug. 10, 2015 M. Raychaudhuri et al., 2011 International Journal of Alzheimer's Disease, 1-5 (2011).* (65) Prior Publication Data J. Richter et al., 171 British Journal of Pharmacology, 158-170 (2014).* US 2016/OO398.41 A1 Feb.
  • Synthetic Studies Toward Aziridinomitosenes and 9-Oxo-Pyrrolo[1,2-A]Indole Mitosanes Related to the Mitomycin and FR Heterocycles

    Synthetic Studies Toward Aziridinomitosenes and 9-Oxo-Pyrrolo[1,2-A]Indole Mitosanes Related to the Mitomycin and FR Heterocycles

    Synthetic Studies Toward Aziridinomitosenes and 9-Oxo-pyrrolo[1,2-a]indole Mitosanes Related to the Mitomycin and FR Heterocycles by Susan D. Wiedner A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Chemistry) in The University of Michigan 2009 Doctoral Committee: Professor Edwin Vedejs, Chair Professor David Sherman Associate Professor Anna Mapp Associate Professor John Wolfe © Susan D. Wiedner 2009 To my grandfather, Francis Jerome Trick ii Acknowledgements I would first like to thank my advisor, Professor Edwin Vedejs, for advising me over the last six years. His drive for understanding chemical problems and discovering new chemistry imparted on me a desire to understand, analyze, and circumvent multiple synthetic difficulties which I encountered during my graduate work. Without his guidance and example, I would not have been successful. Furthermore, I would like to thank him for the opportunity to discover my “talents” during this incredibly challenging and rewarding research experience. I also want to thank past and present Vedejs group members. A special thanks goes to Tim, Trisha, and Drew for helping me transition into the lab during my first and second year. Thank you Jeremy and Musong for your previous work on the FK317 project. Thanks John, Aleks, Li, Dan and Eoghan for many discussions about chemistry. I especially want to thank Bob and Val for their insightful suggestions regarding my project, for reading and editing my thesis, and for their friendship. Most importantly, I would like to thank my family. My husband Eric has been by my side for most of my graduate career and I could not have gotten through this challenging process without his support and love.
  • Automatic Verification of Small Molecule Structure with One Dimensional Proton Nuclear Magnetic Resonance Spectrum

    Automatic Verification of Small Molecule Structure with One Dimensional Proton Nuclear Magnetic Resonance Spectrum

    Automatic Verification of Small Molecule Structure with One Dimensional Proton Nuclear Magnetic Resonance Spectrum DOCTORAL THESIS FOR THE DEGREE OF A DOCTOR OF INFORMATICS AT THE FACULTY OF ECONOMICS, BUSINESS ADMINISTRATION AND INFORMATION TECHNOLOGY OF THE UNIVERSITY OF ZURICH by JIWEN LI from V.R. China Accepted on the recommendation of PROF. DR. A. BERNSTEIN PROF. DR. K. BALDRIDGE 2010 The Faculty of Economics, Business Administration and Information Technology of the University of Zurich herewith permits the publication of the aforementioned dissertation without expressing any opinion on the views contained therein. Zurich, April 14. 2010 The Vice Dean of the Academic Program in Informatics: Prof. Dr. H. C. Gall Contents Acknowledgements .................................................................................................................................... viii Abstract ........................................................................................................................................................ ix List of Figures ................................................................................................................................................ x List of Tables ............................................................................................................................................... xii Part I .............................................................................................................................................................. 1 Introduction,
  • Fluoroarenes for Use in the Medical Imaging Technique

    Fluoroarenes for Use in the Medical Imaging Technique

    DIARYLIODONIUM SALTS AS PRECURSORS TO 18 ELECTRON-RICH [ F]FLUOROARENES FOR USE IN THE MEDICAL IMAGING TECHNIQUE – POSITRON EMISSION TOMOGRAPHY SATWINDER SINGH BHATT Submitted in fulfilment of the requirements for the degree of Doctor of Philosophy. Sir Bobby Robson Foundation PET Tracer Production Unit, School of Chemistry, Newcastle University January 2016 Contents Acknowledgements ....................................................................................... v List of Abbreviations ................................................................................... vii 1 Introduction ......................................................................................... 1 1.1 Positron Emission Tomography ................................................................. 1 1.2 Radioisotopes in PET Imaging ................................................................... 9 1.3 Fluorine in Pharmaceuticals .................................................................... 12 1.4 PET Imaging with Fluorine-18 ................................................................. 17 1.5 Cyclotron Production of Fluorine-18 ......................................................... 19 1.5.1 Radiochemical Terminology ................................................................. 21 1.5.2 Production of Electrophilic Fluorine-18 .................................................. 24 1.5.3 Production of Nucleophilic Fluorine-18 .................................................. 25 1.5.4 Radiopharmaceutical Production .........................................................
  • Bioactivity Screening of Cyanobacteria for the Isolation of Novel Anticancer Compounds M.ICBAS 2018 Using 2D and 3D Cell Culture Models

    Bioactivity Screening of Cyanobacteria for the Isolation of Novel Anticancer Compounds M.ICBAS 2018 Using 2D and 3D Cell Culture Models

    MESTRADO AMBIENTAIS CONTAMINAÇÃO E TOXICOLOGIA Bioactivity screening of cyanobacteria of Bioactivity screening anticancer novel of the isolation for cell 3D and 2D using compounds models culture Leonor do Amaral Silva Ferreira M 2018 Leonor do Amaral Silva Ferreira. Bioactivity screening of cyanobacteria for the isolation of novel anticancer compounds M.ICBAS 2018 using 2D and 3D cell culture models Bioactivity screening of cyanobacteria for the isolation of novel anticancer compounds using 2D and 3D cell culture models Leonor do Amaral Silva Ferreira SEDE ADMINISTRATIVA INSTITUTO DE CIÊNCIAS BIOMÉDICAS ABEL SALAZAR FACULDADE DE CIÊNCIAS Leonor do Amaral Silva Ferreira Bioactivity screening of cyanobacteria for the isolation of novel anticancer compounds using 2D and 3D cell culture models Dissertação de Candidatura ao grau de mestre em Toxicologia e Contaminação Ambientais submetida ao Instituto de Ciências Biomédicas de Abel Salazar da Universidade do Porto Orientador – Doutor Ralph Urbatzka Categoria – Investigador Pós-Doutoramento Afiliação – Centro Interdisciplinar de Investigação Marinha e Ambiental Coorientador – Professor Doutor Vitor Vasconcelos Categoria – Professor Catedrático Afiliação – Faculdade de Ciências da Universidade do Porto/Centro Interdisciplinar de Investigação Marinha e Ambiental Acknowledgements My deepest appreciation goes to my supervisor, Dr Ralph Urbatzka, for all the guidance and support and for all the insights and knowledge shared with me during this work, and to my co-supervisor, Professor Doctor Vitor Vasconcelos, for giving me such a great opportunity to work in this project and in this amazing team. To Dr Marco Preto for all the time, knowledge and help he provided for the chemistry work and to Maria Lígia Sousa for teaching me all about spheroids and for helping me work the results.
  • Syntheses and Evaluation of Phthalocyanine Derivatives For

    Syntheses and Evaluation of Phthalocyanine Derivatives For

    Louisiana State University LSU Digital Commons LSU Doctoral Dissertations Graduate School 2008 Syntheses and Evaluation of Phthalocyanine Derivatives for Applications in Photodynamic and Boron Neutron Capture Therapies for Cancer Hairong Li Louisiana State University and Agricultural and Mechanical College, [email protected] Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations Part of the Chemistry Commons Recommended Citation Li, Hairong, "Syntheses and Evaluation of Phthalocyanine Derivatives for Applications in Photodynamic and Boron Neutron Capture Therapies for Cancer" (2008). LSU Doctoral Dissertations. 3294. https://digitalcommons.lsu.edu/gradschool_dissertations/3294 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please [email protected]. SYNTHESES AND EVALUATION OF PHTHALOCYANINE DERIVATIVES FOR APPLICATIONS IN PHOTODYNAMIC AND BORON NEUTRON CAPTURE THERAPIES FOR CANCER A Dissertation Submitted to the Graduate Faculty of the Louisiana State University and Agricultural and Mechanical College in partial fulfillment of the requirement for the degree of Doctor of Philosophy in The Department of Chemistry By Hairong Li B.S., Nankai University, 2001 M.S., Nankai University, 2004 December, 2008 DEDICATION To my parents: Mingzhen Tang and Baiwen Li. Thank you for being wonderful parents; for giving me life, unconditional love, support, education, guidance, most importantly the freedom to make my own decisions. You have always been my source of strength and inspiration. I can never thank you enough for what you have done in my life.
  • Structural Determination of Torlon 4000T Polyamide-Imide by NMR Spectroscopy Robertson, Gilles; Guiver, Michael; Yoshikawa, M.; Brownstein, Sydney

    Structural Determination of Torlon 4000T Polyamide-Imide by NMR Spectroscopy Robertson, Gilles; Guiver, Michael; Yoshikawa, M.; Brownstein, Sydney

    NRC Publications Archive Archives des publications du CNRC Structural determination of Torlon 4000T polyamide-imide by NMR spectroscopy Robertson, Gilles; Guiver, Michael; Yoshikawa, M.; Brownstein, Sydney This publication could be one of several versions: author’s original, accepted manuscript or the publisher’s version. / La version de cette publication peut être l’une des suivantes : la version prépublication de l’auteur, la version acceptée du manuscrit ou la version de l’éditeur. For the publisher’s version, please access the DOI link below./ Pour consulter la version de l’éditeur, utilisez le lien DOI ci-dessous. Publisher’s version / Version de l'éditeur: https://doi.org/10.1016/j.polymer.2003.12.029 Polymer, 45, 2004 NRC Publications Record / Notice d'Archives des publications de CNRC: https://nrc-publications.canada.ca/eng/view/object/?id=06c75579-15bb-4fb1-b403-590399c28976 https://publications-cnrc.canada.ca/fra/voir/objet/?id=06c75579-15bb-4fb1-b403-590399c28976 Access and use of this website and the material on it are subject to the Terms and Conditions set forth at https://nrc-publications.canada.ca/eng/copyright READ THESE TERMS AND CONDITIONS CAREFULLY BEFORE USING THIS WEBSITE. L’accès à ce site Web et l’utilisation de son contenu sont assujettis aux conditions présentées dans le site https://publications-cnrc.canada.ca/fra/droits LISEZ CES CONDITIONS ATTENTIVEMENT AVANT D’UTILISER CE SITE WEB. Questions? Contact the NRC Publications Archive team at [email protected]. If you wish to email the authors directly, please see the first page of the publication for their contact information.
  • WO 2018/013686 Al 18 January 2018 (18.01.2018) W !P O PCT

    WO 2018/013686 Al 18 January 2018 (18.01.2018) W !P O PCT

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2018/013686 Al 18 January 2018 (18.01.2018) W !P O PCT (51) International Patent Classification: Declarations under Rule 4.17: C07D 209/14 (2006.01) A61K 31/4045 (2006.01) — of inventorship (Rule 4.1 7(iv)) (21) International Application Number: Published: PCT/US20 17/04 1709 — with international search report (Art. (22) International Filing Date: 12 July 2017 (12.07.2017) (25) Filing Language: English (26) Publication Langi English (30) Priority Data: 62/361,3 16 12 July 2016 (12.07.2016) US (71) Applicant: CONCERT PHARMACEUTICALS, INC. [US/US]; 99 Hayden Avenue, Suite 500, Lexington, MA 02421 (US). (72) Inventor: SILVERMAN, I., Robert; 36 Orvis Road, Ar lington, MA 02474 (US). (74) Agent: ABELLEIRA, Susan, M. et al; Foley Hoag LLP, 155 Seaport Boulevard, Boston, MA 02210-2600 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
  • Temperature Dependent Analysis of Octenidine (N,N´-(Decane-1,10-Diyldipyridin- 1-Yl-4-Ylidene)Dioctan-1-Amine) Dihydrochloride by NMR and NIR Spectroscopy

    Temperature Dependent Analysis of Octenidine (N,N´-(Decane-1,10-Diyldipyridin- 1-Yl-4-Ylidene)Dioctan-1-Amine) Dihydrochloride by NMR and NIR Spectroscopy

    The Free Internet Journal Paper for Organic Chemistry Archive for Arkivoc 2020, part vi, 287-298 Organic Chemistry Temperature dependent analysis of Octenidine (N,N´-(decane-1,10-diyldipyridin- 1-yl-4-ylidene)dioctan-1-amine) dihydrochloride by NMR and NIR spectroscopy David L. Mainka,a* Jörg Schwarz,b and Ulrich Girreserb aInstitute of Pharmacy, University of Greifswald,Friedrich-Ludwig-Jahn-Str. 17, 17489 Greifswald bInstitute of Pharmacy, University of Kiel, Gutenbergstr. 76, 24118 Kiel Email: [email protected] Received 03-02-2020 Accepted 05-11-2020 Published on line 08-24-2020 Abstract Octenidine dihydrochloride is one of the most common active pharmaceutical incredients with a disinfectant effect on superficial wounds. In this paper we describe the mesomeric behaviour of Octenidine dihydrochloride by comparison with 1H, 13C and 15N NMR shift data. With various NMR experiments, the possible mesomeric structures are studied and it is shown that an E/Z-isomerization plays a role, corresponding to a hindered rotation of the heteroaromatic pyridine ring. In this context, NIR spectroscopy and principal component analysis emphasize the occurrence of a modified temperature-dependent spectral behaviour of Octenidine dihydrochloride. In addition, we made a detailed study of the NMR-characteristics of Octenidine dihydrochloride using 1D- and 2D-experiments. Keywords: Octenidine dihydrochloride, E/Z isomerization, NIR spectroscopy, NMR spectroscopy, nitrogen heterocycles DOI: https://doi.org/10.24820/ark.5550190.p011.189 Page 287 ©AUTHOR(S)
  • Hélène LAJOUS

    Hélène LAJOUS

    THESE DE DOCTORAT DE L'UNIVERSITE D'ANGERS L'UNIVERSITE DE LIEGE COMUE UNIVERSITE BRETAGNE LOIRE ECOLE DOCTORALE N° 605 ECOLE DOCTORALE Biologie Santé Chimie moléculaire, supramoléculaire et fonctionnelle Spécialité : Technologies biomédicales, Vectorisation, Nanomédecine, Thérapie cellulaire et génique, Médecine régénératrice et Biomatériaux Par Hélène LAJOUS Cisplatine : une vieille molécule pour de nouveaux défis Développement d’une prodrogue macromoléculaire multifonctionnelle applicable au traitement local du glioblastome Thèse présentée et soutenue à Angers, le 22 mai 2018 Unités de recherche : Centre de Recherche en Cancérologie et Immunologie Nantes Angers (CRCINA), INSERM U1232 Centre d’Etude et de Recherche sur les Macromolécules (CERM) Rapporteurs avant soutenance : Pr. Karine ANDRIEUX Professeure, Université Paris Descartes Dr. Sandrine CAMMAS-MARION Chargée de recherche, CNRS, HDR, Ecole Nationale Supérieure de Chimie de Rennes Composition du Jury : Pr. Christine JEROME Professeure, Université de Liège Présidente Pr. Karine ANDRIEUX Professeure, Université Paris Descartes Dr. Sandrine CAMMAS-MARION Chargée de recherche, CNRS, HDR, Ecole Nationale Supérieure de Chimie de Rennes Dr. Elodie VAULEON MD, PhD, Centre Eugène Marquis, Service d’Oncologie Médicale, Université de Rennes Dr. Caroline ROBIC PhD, Guerbet Dr. Emmanuel GARCION Directeur de recherche, INSERM, Université d’Angers Directeur de thèse Dr. Philippe LECOMTE Chercheur, FNRS, Université de Liège Co-directeur de thèse An Seppi “One day, we imagine that cancer biology and treatment – at present, a patchwork quilt of cell biology, genetics, histopathology, biochemistry, immunology, and pharmacology – will become a science with a conceptual structure and logical coherence that rivals that of chemistry or physics.” Douglas Hanahan & Robert A. Weinberg, 2000. The hallmarks of cancer. Cell, 100, pp.
  • Colón Santos, Stephanie Marie (2019) Exploring the Untargeted Synthesis of Prebiotically-Plausible Molecules

    Colón Santos, Stephanie Marie (2019) Exploring the Untargeted Synthesis of Prebiotically-Plausible Molecules

    Colón Santos, Stephanie Marie (2019) Exploring the untargeted synthesis of prebiotically-plausible molecules. PhD thesis. https://theses.gla.ac.uk/75152/ Copyright and moral rights for this work are retained by the author A copy can be downloaded for personal non-commercial research or study, without prior permission or charge This work cannot be reproduced or quoted extensively from without first obtaining permission in writing from the author The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the author When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given Enlighten: Theses https://theses.gla.ac.uk/ [email protected] Exploring the Untargeted Synthesis of Prebiotically-Plausible Molecules A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy School of Chemistry College of Science and Engineering University of Glasgow Presented by Stephanie Marie Colón-Santos September 2019 Acknowledgements 3 Acknowledgements The work presented in this thesis was carried out between February 2016 and August 2019 in the group of Prof. Leroy Cronin in the School of Chemistry at the University of Glasgow. Through-out the years, I received the help and support of several group members. In particular, I would like to express my sincere gratitude to the following people: Prof Leroy Cronin, for taking me on as an intern in June 2015 and giving the opportunity to start a PhD in his research group. It has been a life-changing experience.